I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Novel Dosing Strategies Increase Exposures of the Potent An..:
Dooley, Kelly E
;
Savic, Radojka M
;
Park, Jeong-Gun
...
qt69r434hg. , 2015
Link:
https://escholarship.org/uc/item/69r434hg
RT Journal T1
Novel Dosing Strategies Increase Exposures of the Potent Antituberculosis Drug Rifapentine but Are Poorly Tolerated in Healthy Volunteers
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt69r434hg&Exemplar=1&LAN=DE A1 Dooley, Kelly E A1 Savic, Radojka M A1 Park, Jeong-Gun A1 Cramer, Yoninah A1 Hafner, Richard A1 Hogg, Evelyn A1 Janik, Jennifer A1 Marzinke, Mark A A1 Patterson, Kristine A1 Benson, Constance A A1 Hovind, Laura A1 Dorman, Susan E A1 Haas, David W PB eScholarship, University of California YR 2015 K1 Pharmacology and Pharmaceutical Sciences K1 Biomedical and Clinical Sciences K1 Tuberculosis K1 Rare Diseases K1 Patient Safety K1 Orphan Drug K1 Prevention K1 Clinical Trials and Supportive Activities K1 Clinical Research K1 6.1 Pharmaceuticals K1 Evaluation of treatments and therapeutic interventions K1 Good Health and Well Being K1 Adolescent K1 Adult K1 Aged K1 Antitubercular Agents K1 Drug Administration Schedule K1 Female K1 Healthy Volunteers K1 Humans K1 Male K1 Middle Aged K1 Rifampin K1 Young Adult K1 ACTG A5311 Study Team K1 Microbiology K1 Medical Microbiology JF qt69r434hg LK http://dx.doi.org/https://escholarship.org/uc/item/69r434hg DO https://escholarship.org/uc/item/69r434hg SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)